Microbiome Manufacturing Market Size to Hit USD 130.37 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Microbiome Manufacturing Market

5.1. COVID-19 Landscape: Microbiome Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Microbiome Manufacturing Market, By Product Type

8.1. Microbiome Manufacturing Market Revenue and Volume Forecast, by Product Type

8.1.1. Live Biotherapeutics

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Probiotics

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Prebiotics

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Microbiome-targeted Therapeutics

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Microbiome Manufacturing Market, By Manufacturing Process

9.1. Microbiome Manufacturing Market Revenue and Volume Forecast, by Manufacturing Process

9.1.1. Fermentation

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Downstream Processing

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Formulation & Packaging

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Quality Control & Testing

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Microbiome Manufacturing Market, By End User

10.1. Microbiome Manufacturing Market Revenue and Volume Forecast, by End User

10.1.1. Pharmaceutical & Biotechnology Companies

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Contract Development & Manufacturing Organizations (CDMOs)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Research Institutes & Academic Centers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Nutraceutical & Food Companies

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Hospitals & Clinical Trial Centers

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Microbiome Manufacturing Market, By Technology / Platform

11.1. Microbiome Manufacturing Market Revenue and Volume Forecast, by Technology / Platform

11.1.1. Anaerobic Fermentation Platforms

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Aerobic Fermentation Platforms

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Microfluidics-based Culturing

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Automated High-throughput Systems

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Single-use Bioreactors

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Microbiome Manufacturing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.1.3. Market Revenue and Volume Forecast, by End User

12.1.4. Market Revenue and Volume Forecast, by Technology / Platform

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.1.5.3. Market Revenue and Volume Forecast, by End User

12.1.5.4. Market Revenue and Volume Forecast, by Technology / Platform

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.1.6.3. Market Revenue and Volume Forecast, by End User

12.1.6.4. Market Revenue and Volume Forecast, by Technology / Platform

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.2.3. Market Revenue and Volume Forecast, by End User

12.2.4. Market Revenue and Volume Forecast, by Technology / Platform

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.2.5.3. Market Revenue and Volume Forecast, by End User

12.2.5.4. Market Revenue and Volume Forecast, by Technology / Platform

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.2.6.3. Market Revenue and Volume Forecast, by End User

12.2.6.4. Market Revenue and Volume Forecast, by Technology / Platform

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.2.7.3. Market Revenue and Volume Forecast, by End User

12.2.7.4. Market Revenue and Volume Forecast, by Technology / Platform

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.2.8.3. Market Revenue and Volume Forecast, by End User

12.2.8.4. Market Revenue and Volume Forecast, by Technology / Platform

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.3.3. Market Revenue and Volume Forecast, by End User

12.3.4. Market Revenue and Volume Forecast, by Technology / Platform

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.3.5.3. Market Revenue and Volume Forecast, by End User

12.3.5.4. Market Revenue and Volume Forecast, by Technology / Platform

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.3.6.3. Market Revenue and Volume Forecast, by End User

12.3.6.4. Market Revenue and Volume Forecast, by Technology / Platform

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.3.7.3. Market Revenue and Volume Forecast, by End User

12.3.7.4. Market Revenue and Volume Forecast, by Technology / Platform

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.3.8.3. Market Revenue and Volume Forecast, by End User

12.3.8.4. Market Revenue and Volume Forecast, by Technology / Platform

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.4.3. Market Revenue and Volume Forecast, by End User

12.4.4. Market Revenue and Volume Forecast, by Technology / Platform

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.4.5.3. Market Revenue and Volume Forecast, by End User

12.4.5.4. Market Revenue and Volume Forecast, by Technology / Platform

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.4.6.3. Market Revenue and Volume Forecast, by End User

12.4.6.4. Market Revenue and Volume Forecast, by Technology / Platform

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.4.7.3. Market Revenue and Volume Forecast, by End User

12.4.7.4. Market Revenue and Volume Forecast, by Technology / Platform

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.4.8.3. Market Revenue and Volume Forecast, by End User

12.4.8.4. Market Revenue and Volume Forecast, by Technology / Platform

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.5.3. Market Revenue and Volume Forecast, by End User

12.5.4. Market Revenue and Volume Forecast, by Technology / Platform

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.5.5.3. Market Revenue and Volume Forecast, by End User

12.5.5.4. Market Revenue and Volume Forecast, by Technology / Platform

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Manufacturing Process

12.5.6.3. Market Revenue and Volume Forecast, by End User

12.5.6.4. Market Revenue and Volume Forecast, by Technology / Platform

Chapter 13. Company Profiles

13.1. 4D Pharma

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Abbott

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. ActoBio Therapeutics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. AOBiome

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Axcella Health

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. BioGaia

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. BiomX

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Exeliom Biosciences

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. Ferring Pharmaceuticals

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. Finch Therapeutics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The microbiome manufacturing market size is expected to increase from USD 26.98 billion in 2024 to USD 130.37 billion by 2034.

The microbiome manufacturing market is expected to grow at a compound annual growth rate (CAGR) of around 17.06% from 2025 to 2034.

The major players in the microbiome manufacturing market include 4D Pharma, ActoBio Therapeutics, AOBiome, Axcella Health, BioGaia, BiomX, Enterome, Exeliom Biosciences, Ferring Pharmaceuticals, Finch Therapeutics, MaaT Pharma, Microbiotica, NuBiyota, Prokarium, Rebiotix (a Ferring Company), Second Genome, Seres Therapeutics, Synlogic, Vedanta Biosciences, and Evelo Biosciences.

The driving factors of the microbiome manufacturing market are the rising investments in microbiome research, regulatory approvals of live microbial therapeutics, and the expansion of GMP-compliant manufacturing capabilities.

North America region will lead the global microbiome manufacturing market during the forecast period 2025 to 2034.